2010
DOI: 10.1097/aci.0b013e32833903a6
|View full text |Cite
|
Sign up to set email alerts
|

Role of intermittent hypoxia in the treatment of bronchial asthma and chronic obstructive pulmonary disease

Abstract: Recent research outlines the value of IHT as a therapeutic strategy for the treatment of COPD patients, leading to more efficient ventilation. Additionally, IHT might represent an attractive method to complement the known beneficial effects of exercise training and to rebalance early autonomic dysfunction in COPD patients. Future research examining the potential risks and benefits of IHT could pave the way for the development of new therapeutic approaches for patients suffering from bronchial asthma and COPD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 49 publications
1
13
0
Order By: Relevance
“…This was seen in acute and chronic models of asthma but was not seen in normal uninflamed lungs. We speculate that induction of the hypoxia response in the bronchial epithelium, as seen in control mice with a mild asthma phenotype, is a protective mechanism to attenuate cell injury and apoptosis (3,25,26). This best explains the observed protective effect of low-dose DHB inhibition in the chronic model and is consistent with other reports where accentuation of the hypoxic response or loss of prolyl hydroxylases leads to increased cell survival (25).…”
Section: Discussionsupporting
confidence: 90%
“…This was seen in acute and chronic models of asthma but was not seen in normal uninflamed lungs. We speculate that induction of the hypoxia response in the bronchial epithelium, as seen in control mice with a mild asthma phenotype, is a protective mechanism to attenuate cell injury and apoptosis (3,25,26). This best explains the observed protective effect of low-dose DHB inhibition in the chronic model and is consistent with other reports where accentuation of the hypoxic response or loss of prolyl hydroxylases leads to increased cell survival (25).…”
Section: Discussionsupporting
confidence: 90%
“…zebrafish) [48] based on different exposure times and hypoxia levels in order to make it possible the transfer of results to humans. These findings could be of particular interest for the selection of specific molecular targets for prognosis or for pharmacological interventions in diseases like COPD in which muscle adaptation to hypoxia can facilitate a positive outcome [49]. The described results underline the potential of differential proteomics in providing new insight into the mechanisms of adaptation to reduced O 2 pressure in conditions in which hypoxia is not the consequence of a disease.…”
Section: Subacute Hypoxiamentioning
confidence: 64%
“…Hence the study of MRPL4, BCAP other molecules involved in the HIF-1α and PI3K/Akt signaling pathways might help understand the pathophysiology of allergic rhinitis and other atopic phenotypes. Recent research has also shown promise of therapeutic intervention of the HIF-1α as well PI3K/Akt signaling pathways for treatment of asthma and other related allergic conditions [57], [58], [59].…”
Section: Discussionmentioning
confidence: 99%